After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Oruka Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Oruka Therapeutics Inc is $1.55B. A total of 0.26 million shares were traded on the day, compared to an average of 531.90K shares.
In the most recent transaction, Goncalves Joana sold 7,000 shares of ORKA for 30.61 per share on Dec 19 ’25. After the transaction, the Chief Medical Officer now owns 1,518 company shares. In a previous transaction on Dec 19 ’25, JOANA GONCALVES bought 28,000 shares at 28.15 per share.
Among the insiders who bought shares, Venrock Healthcare Capital Par acquired of 88,794 shares on Feb 14 ’25 at a per-share price of $11.44. This resulted in the 10% Owner holding 4,148,428 shares of ORKA after the transaction. In another insider transaction, Venrock Healthcare Capital Par bought 14,950 shares at $11.63 per share on Feb 13 ’25. Company shares held by the 10% Owner now total 4,059,634.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ORKA has a high of $32.64 and a low of $5.49.
As of this writing, ORKA has an earnings estimate of -$0.63 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.47 per share and a lower estimate of -$0.85. The company reported an EPS of -$0.49 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORKA is Buy with a score of 4.85.
